References
- American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders (DSM IV), 4th Ed. (APA, Washington, D.C.).
- Brown, S., Birtwistle, L.R. and Thompson, C. (1999 ) “The unhealthy lifestyle of people with schizophrenia”, Psychological Medicine 29, 697–701.
- Brown, S., Inskip, H. and Barraclough, B. (2002 ) “Causes of the excess mortality of schizophrenia”, British Journal of Psychiatry 177, 212–217.
- Christensen, O. and Christensen, E. (1988 ) “Fat consumption and schizophrenia”, Acta Psychiatrica Scandinavica 78, 587–591.
- Gregory, J., Foster, K., Tyler, H. and Wiseman, M. (1990) The Dietary and Nutritional Survey of British Adults (HMSO, London).
- Mc Creadie, R., MacDonald, E., Blacklock, C., et al. (1998 ) “Dietary intake of schizophrenic patients in Nithsdale, Scotland: a case- control study”, British Medical Journal 317, 784–785.
- Mellor, J.E., Laugharne, J.D.E. and Peet, M. (1996) “Omega-3 fatty acid supplementation in schizophrenic patients”, Human Psychopharmacology. 11, 39–46.
- Meltzer, H.Y., Perry, E. and Jayathilake, K. (2003 ) “Clozapine- induced weight gain predicts improvement in psychopathology”, Schizophrenia Research 59(1), 19–27.
- Overall, J.E. and Gorham, D.R. (1962 ) “The brief psychiatric rating scale”, Psychology Reports 10, 799–812.
- Peet, M. (2002 ) “Essential fatty acids: Theoretical aspects and treatment implications for schizophrenia and depression”, Advances in Psychiatric Treatment 8, 223–229.
- Peet, M. (2004 ) “International variations in the outcome of schizophrenia and the prevalence of depression in relation to national dietary practices: an ecological analysis”, British Journal of Psychiatry 184, 404–408.
- Sernyak, M.J., Leslie, D.L., Alarcon, R.D., et al. (2002 ) “Associates of diabetes mellitus with use of a typical neuroleptics in the treatment of schizophrenia”, American Journal of Psychiatry 159, 561–566.